Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06895187 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Catheter Ablation Using a Novel Navigation and Imaging System

Study acronym: ENVIsIoN
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Nov 1, 2026 to Jan 1, 2027
    • Study completion pushed from Nov 1, 2027 to Dec 1, 2027
    • Eligibility criteria expanded, about 4 words
  2. Start date: Oct 1, 2026 to Nov 1, 2026
    • Primary and study completion pushed from Oct 1, 2027 to Nov 1, 2027
    v12
  3. Start date: Sep 1, 2026 to Oct 1, 2026
    • Primary and study completion pushed from Sep 1, 2027 to Oct 1, 2027
    v11
  4. Start date: Aug 1, 2026 to Sep 1, 2026
    • Primary and study completion pushed from Aug 1, 2027 to Sep 1, 2027
    v10
  5. Start date: Jul 1, 2026 to Aug 1, 2026
    • Primary and study completion pushed from Jul 1, 2027 to Aug 1, 2027
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. Re-verified, no change to tracked fieldsv8
  2. Start date: Mar 1, 2026 to Jul 1, 2026
    • Primary and study completion dates: Mar 1, 2027 to Jul 1, 2027
    v7
  3. Start date: Dec 1, 2025 to Mar 1, 2026
    • Primary and study completion dates: Jan 1, 2027 to Mar 1, 2027
    v6
  4. Start date: Nov 1, 2025 to Dec 1, 2025
    • Primary and study completion dates: Dec 1, 2026 to Jan 1, 2027
    v5
  5. Start date: Oct 1, 2025 to Nov 1, 2025
    • Primary and study completion dates: Nov 1, 2026 to Dec 1, 2026
    v4
  6. Start date: Sep 1, 2025 to Oct 1, 2025
    • Primary and study completion dates: Oct 1, 2026 to Nov 1, 2026
    v3
  7. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the ENVIsIoN study is to collect data on the use of the VERAFEYE navigation and imaging system in patients indicated to undergo a catheter ablation procedure for the treatment of Paroxysmal Atrial Fibrillation (PAF).
Trial Details
NCT Number NCT06895187
Lead Sponsor LUMA Vision Ltd.
Conditions
(from sponsor)		 Paroxysmal Atrial Fibrillation
Related terms Atrial Fibrillation
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov